D-Wave Quantum Inc. filed a Form 8-K on October 28, 2026, disclosing a non-binding memorandum of understanding with LG CNS Co., Ltd. and a NEDO Challenge award won by D-Wave customer Shionogi & Co., Ltd.

Key Highlights

  • MOU signed: D-Wave Quantum and LG CNS Co., Ltd. signed a non-binding memorandum of understanding to advance quantum computing adoption for enterprise optimization in South Korea and international markets.
  • Target industries: The companies intend to develop applications for customers in manufacturing, telecommunications, finance, and retail, according to the filing.
  • Conference announcement: D-Wave CEO Dr. Alan Baratz and LG CNS President and CEO Hyun Shin-Gyoon announced the MOU onstage at D-Wave's Qubits Asia conference in Seoul.
  • Shionogi award: D-Wave customer Shionogi & Co., Ltd. won first place in the Quality of Life category of the NEDO Challenge for research applying quantum computing to drug discovery.
  • NEDO prize value: The NEDO prize awarded to Shionogi was ¥40 million, which the filing states will support continued quantum computing research in drug discovery.
  • Molecular validity finding: The award-winning peer-reviewed study reported that 97% of molecular representations generated by the quantum-assisted model were chemically valid, compared with 73% using an equivalent classical model.

D-Wave and LG CNS Target Enterprise Quantum Optimization, While Shionogi Earns NEDO Recognition

D-Wave Quantum Inc. (NASDAQ:QBTS) disclosed two separate announcements in its October 28, 2026 Form 8-K filing under Item 7.01 Regulation FD Disclosure. First, D-Wave and LG CNS Co., Ltd., described in the filing as "a leading AI transformation company in South Korea," signed a non-binding MOU. The filing states the collaboration will focus on applying D-Wave's annealing quantum computing technology to complex optimization challenges, "with the goal of moving applications from proof of concept into production."

According to the filing, the companies intend to combine D-Wave's annealing quantum computing technologies with LG CNS's industry expertise, mathematical optimization capabilities, and systems integration experience. The two parties also intend to pursue joint go-to-market opportunities. The MOU was announced onstage at D-Wave's Qubits Asia conference in Seoul by D-Wave CEO Dr. Alan Baratz and LG CNS President and CEO Hyun Shin-Gyoon.

The second disclosure involves D-Wave customer Shionogi & Co., Ltd., which the filing reports won first place in the Quality of Life (QOL) category of the NEDO Challenge. The award-winning research included a peer-reviewed study published in Scientific Reports in July 2026, which, according to the filing, "integrated D-Wave annealing quantum computing technology into a generative AI model for molecular design." The filing states that the quantum-assisted model generated a higher proportion of molecules with strong drug-likeness scores, exceeding both the classical model and the training dataset. The ¥40 million NEDO prize, the filing notes, will support Shionogi's continued research into applying quantum computing to drug candidate molecule design. The filing specifies that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

What Was Disclosed

D-Wave Quantum filed an 8-K on October 28, 2026, disclosing a non-binding MOU with LG CNS to pursue quantum computing applications in South Korea and globally, and reporting that customer Shionogi won a ¥40 million NEDO Challenge award for quantum-assisted drug discovery research.